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Streptomyces diastatochromogenes Tü6028 is known to produce the polyketide
antibiotic polyketomycin. The deletion of the pokOIV oxygenase gene led to a non-
polyketomycin-producing mutant. Instead, novel compounds were produced by the
mutant, which have not been detected before in the wild type strain. Four different
compounds were identified and named foxicins A–D. Foxicin A was isolated and its
structure was elucidated as an unusual nitrogen-containing quinone derivative using
various spectroscopic methods. Through genome mining, the foxicin biosynthetic gene
cluster was identified in the draft genome sequence of S. diastatochromogenes. The
cluster spans 57 kb and encodes three PKS type I modules, one NRPS module and
41 additional enzymes. A foxBII gene-inactivated mutant of S. diastatochromogenes
Tü6028 1pokOIV is unable to produce foxicins. Homologous fox biosynthetic gene
clusters were found in more than 20 additional Streptomyces strains, overall in about
2.6% of all sequenced Streptomyces genomes. However, the production of foxicin-like
compounds in these strains has never been described indicating that the clusters are
expressed at a very low level or are silent under fermentation conditions. Foxicin A acts
as a siderophore through interacting with ferric ions. Furthermore, it is a weak inhibitor
of the Escherichia coli aerobic respiratory chain and shows moderate antibiotic activity.
The wide distribution of the cluster and the various properties of the compound indicate
a major role of foxicins in Streptomyces strains.
Keywords: Streptomyces, natural product, foxicin, biosynthetic gene cluster, evolution, siderophore
Abbreviations: A domain, adenylation domain; ACP, acyl carrier protein; C domain, condensation domain; CAS,
chrome azurol S; DFT, density functional theory; DH, dehydratase; EtOAc, ethyl acetate; IR, infrared; KR, ketoreductase;
KS, ketosynthase; Mbp, mega base pairs; mMFF, molecular mechanics; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide; NRPS, non-ribosomal peptide synthetase; PCP, peptidyl carrier protein; PKS, polyketide synthase; VCD,
vibrational circular dichroism; wt, wild type.
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INTRODUCTION
Plants, marine organisms, protozoans, fungi, and bacteria
produce a wide range of different secondary metabolites. They are
not essential for normal growth, development, or reproduction
of an organism, but play a secondary role. There have been
several discussions about the selective advantage of these
natural products for their producers (Firn and Jones, 2000).
Secondary metabolites may act as signals for differentiation, as
communication molecules, or as weapons to defend against food
competitors (Demain and Fang, 2000) and thus they often possess
vital functions in their ecological habitat. The genes responsible
for the biosynthesis of a compound are often located next to
each other in so called biosynthetic gene clusters. The clusters
often span more than 100 kb and encode more than 30 genes
related to biosynthesis, transport, regulation, self-resistance and
modification. Due to their antibiotic, antitumor, cholesterol-
lowering, immunosuppressant or antiviral activities, secondary
metabolites are invaluable elements of drug discovery research
(Vaishnav and Demain, 2011). Approximately 18.000 bioactive
secondary metabolites are produced in bacteria, thereof more
than 10.000 compounds are synthesized in Streptomyces (Bérdy,
2012). Representatives of the genus Streptomyces have been
studied extensively in the last decades (Weber et al., 2015b).
A well-known class of bioactive secondary metabolites are
polyketides that are assembled by modular megaenzymes called
PKSs. The subsequent steps in the assembly process are highly
similar to the biosynthesis of fatty acids. A detailed introduction
to PKS can be found in Staunton and Weissman (2001). Non-
ribosomal peptides (NRP) belong to another important class of
bioactive compounds. They are synthesized by non-ribosomal
peptide synthetase (NRPS) that share certain characteristics with
PKS (see Schwarzer et al., 2003 for details).
The genome size of Streptomyces ranges from 8 to 9 Mb
and shows a high GC (>70%) content. After sequencing the
first Streptomyces genomes it was noticed that unexpectedly,
it contained far more secondary metabolite gene clusters than
had been predicted earlier from the numbers of previously
identified metabolites (Bentley et al., 2002; Ikeda et al., 2003).
Under laboratory conditions Streptomyces and other secondary
metabolite producers synthesize only a few compounds, whereas
more than twenty different secondary metabolite gene clusters are
contained within most genomes.
The presence of similar biosynthetic gene clusters in different
strains reflects their evolutionary history through vertical as
well as horizontal gene transfer from one organism to another,
also across species barriers. Individual genes, sub-clusters or
whole clusters can be exchanged (Egan et al., 2001; Metsä-
Ketelä et al., 2002; Donadio et al., 2005). Consequently,
the secondary metabolites from similar clusters may vary as
they are often built up of distinct moieties from functional
sub-clusters. Therefore, biosynthetic gene clusters are ideal
to study evolutionary routes and to gain knowledge of the
metabolite’s importance to a particular strain (Fischbach et al.,
2008).
The activation of cryptic biosynthetic gene clusters is one
main goal in Streptomyces research to obtain more and
FIGURE 1 | Structure of foxicin A. The structure of foxicin A was elucidated
as (S)-2-hydroxy-3-(acetylamino)-5-(3′ ′, 5′ ′S, 7′ ′-trimethyl-hepta-3′ ′E,
6′ ′-dienoylamino)-1,4-benzoquinone.
novel bioactive compounds to meet the growing requirements
of modern medicine. Potential approaches to successfully
activate a gene cluster are summarized in the following
paragraph.
The cloning and heterologous expression of complete
clusters is one strategy to get access to the genetic potential
of Streptomyces (Gomez-Escribano and Bibb, 2014). In
addition, silent secondary metabolite gene clusters can
be activated through genetic manipulation, e.g., by over-
expression or deletion of proposed global or specific positive
or negative regulatory genes (Makitrynskyy et al., 2013;
Gessner et al., 2015). Furthermore, the cultivation of a given
strain under different fermentation conditions (Bode et al.,
2002) or the co-cultivation with bacterial or fungal strains
(Schroeckh et al., 2009) might stimulate the expression of silent
clusters.
Streptomyces diastatochromogenes Tü6028 is known to
produce the antimicrobial compound polyketomycin, a
tetracyclic quinone glycoside (Paululat et al., 1999). Recently,
we deleted the oxygenase gene pokOIV in this strain, resulting
in a polyketomycin non-producing mutant (Daum et al., 2009).
However, new natural products were synthesized in this mutant.
These metabolites were named foxicins A–D. Possibly, foxicins
are also produced by the wild type strain but only in little
amounts.
In this study we report on the purification and structural
elucidation of foxicin A. The compound consists of an unusual
nitrogen-containing quinone moiety linked to a short fatty acid
(Figure 1).
Furthermore, we identified the corresponding gene cluster,
encoding a type I polyketide synthase (PKS I) and an NRPS in
the genome of S. diastatochromogenes Tü6028. By gene disruption
we show that this cluster is responsible for the production of
foxicin and we propose the biosynthetic pathway of foxicin A.
Similar gene clusters were detected in many other Streptomyces
genomes. Nevertheless, as no foxicin-like compound has been
described so far, we conclude that these clusters are either
not expressed or expressed at a very low level under culture
conditions.
Foxicin A shows several interesting biological properties: it
acts as siderophore binding ferric ions, it shows antibiotic activity
and inhibits respiratory electron transfer. The wide distribution
of the cluster and the various properties of the compound indicate
a major role of foxicin in Streptomyces strains.
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MATERIALS AND METHODS
Bacterial Culture Condition and
Production Analysis
The isolation of polyketomycin of the wild type (wt) strain
S. diastatochromogenes Tü6028 has been described previously
(Paululat et al., 1999). The mutant S. diastatochromogenes
1pokOIV (Daum et al., 2009) contains a deletion in
pokOIV, a gene encoding an oxygenase involved in the
biosynthesis of polyketomycin. Mycelium of the mutant strain
S. diastatochromogenes 1pokOIV was used to inoculate a
300 mL Erlenmeyer flask containing 100 mL of HA medium
(yeast extract 0.4%, malt extract 1%, and glucose 0.4% in 1 liter
tap water, pH 7.3). The flask was shaken on a rotary shaker
(180 rpm) at 28◦C. After 48 h, 3 mL of the pre-culture was
used to inoculate a second 300 mL Erlenmeyer flask containing
100 mL of HA medium (main culture). After 6 days foxicin A
was isolated.
To determine the time dependency of product formation
(foxicin A and polyketomycin) the wt strain was grown in 100 mL
HA medium for 6 days. Samples were taken after 0, 24, 36, 48, 60,
72, 96, 120, and 144 h of cultivation.
To check the influence of iron on the production of foxicin
A, 0.01, 0.1, or 1 mM of FeCl3 or FeSO4 were added to
the production media of S. diastatochromogenes 1pokOIV. The
experiment was done in triplicate. The strain was incubated for
6 days and the culture was extracted and analyzed by HPLC. For
quantification, the integrals of the corresponding chromatogram
peaks were compared.
Isolation of Foxicin A
Mycelium was collected by centrifugation and foxicin A was
extracted with acetone (2–3 times the volume of the pellet)
by shaking at room temperature for 15 min. After removal
of the mycelium by filtration, the extract was evaporated.
Finally, this mycelium extract combined with the supernatant
was extracted with an equal volume of ethyl acetate. The
solvent was removed by evaporation. The crude extract was
separated by solid phase chromatography (Oasis HLB 20/35cc)
with increasing methanol content (in 10% increments) in the
mobile phase. Foxicin A was obtained in the 65 and 70%
methanol fraction, foxicin B and C in the 70 and 80% methanol
fraction, and foxicin D in the 80% methanol fraction. After
thin-layer chromatography in ethyl acetate: formic acid :water
(44:3:3) foxicin A (Rf 0.41) was further purified by semi-
preparative HPLC (Agilent Technologies), equipped with a
Zorbax B-C18 (9.4 × 150 mm) pre-column and Zorbax B-C18
(9.4 mm × 20 mm) main column with acetonitrile + 0.5%
acetic acid as buffer A and water + 0.5% acetic acid as
buffer B and a flow rate of 2 mL/min. A 3-min washing
step with 50% buffer A was followed by a 7-min linear
gradient from 50 to 70% of buffer A where the substance
was collected. The eluate was dried and resulted in a violet
powder. The method was completed by a 4-min delay with
95% buffer A and a 4-min reequilibration step with 50%
buffer A.
Analysis of Foxicin by HPLC/MS
For analysis, HPLC-MS equipped with a XBridge C18 (3.5 µm;
20 mm × 4.6 mm) precolumn and a XBridge C18 (3.5 µm;
100 mm × 4.6 mm) main column, an UV/visible light detector
and a mass spectrometer (Agilent, 1100 Series) was used. A flow
rate of 0.5 mL/min was used. A 1-min washing step with 20%
buffer A was followed by a 7-min linear gradient from 20 to 60%
buffer A and a 16-min linear gradient ranges from 60 to 95%
buffer A. After a 5-min delay the method completed with a 1-min
gradient from 95 to 20% buffer A and a 5-min reequilibration step
with 20% buffer A.
Structure Elucidation by NMR, VCD, and
IR Measurements
The exact mass was analyzed on a MAT 95XL-mass spectrometer
(Thermo Electron Corporation). 1H (600 MHz), 13C (150 MHz),
and 2D NMR (HSQC, HMBC, 1H-1H COSY) spectra were
carried out on a Varian NMR-S600. Chemical shifts are expressed
in δ values (ppm), using the correspondent solvent as internal
reference (CDCl3: δH = 7.25, δC = 77.0 ppm at T = 25◦C or
DMSO-d6: δH = 2.50, δC = 39.5 ppm at T= 35◦C).
Infrared measurements were carried out on a BRUKER Tensor
27 FT-IR spectrometer equipped with a BRUKER PMA 50 VCD
module (Bruker Optik GmbH, Ettlingen). A 100 mM foxicin
A solution was prepared in anhydrous CDCl3 and placed in a
BaF2 cell with a path length of 110 µm. Experimental spectra (4
cm−1 resolution) represent the average of a 6 h measurement in
a rotating cell. IR spectra were corrected by subtraction of the
solvent spectrum. VCD spectra were background corrected by
solvent subtraction and smoothed by Fourier filtering (8 cm−1
resolution). The aperture of the light source was adjusted to a
width of 4 mm. Opus 7.0 software (Bruker Corporation) was used
to analyze the spectra.
Conformer Search and Quantum
Chemical Calculations
The conformer search was carried out at the MMFF level
using Spartan 08 (Wavefunction, Inc., Irvine, CA, USA) and
gave a set of 84 possible conformers. The five conformers
with the highest population (according to Boltzmann weights
calculated in respect to relative energies) account for >99% of
the calculated Boltzmann distribution. These conformers were
chosen for quantum chemical calculations at the DFT level
[B3LYP/6-31+G(d,p)] in Gaussian 09, Revision D.01 (Frisch
et al., 2013). All calculations were performed in gas phase,
vibrational frequencies were uniformly scaled by an empirical
factor of 0.975. Theoretical spectra for each geometry were
obtained by adding Lorentzian band shapes (width 6 cm−1) to
the calculated IR and VCD intensities. The dissymmetry factor
spectrum defined as VCD over IR absorbance was obtained with
CDSpecTech (Covington and Polavarapu, 2013, 2014).
Single Crossover of foxBII in
S. diastatochromogenes 1pokOIV
To construct a single crossover of foxBII gene (PKS I/NRPS
hybrid gene) an internal 2 kb fragment was amplified (primers
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GCCGGGAAGCTTGTCCTCTTCGCCTC and GTCGTCGGA
TCCTGCGC CGCCTCGG). The fragment was cloned into
pKC1132 (Bierman et al., 1992) at HindIII/BamHI cloning site
and transferred into Escherichia coli ET12567 (dam-, dcm-, hsdS-
, cmr) (MacNeil et al., 1992), including conjugation plasmid
pUZ8002 (Flett et al., 1997). Positive transformants were selected
on LB agar supplemented with kanamycin (30 µg mL−1) and
apramycin (50 µg mL−1). The plasmid was transferred into
S. diastatochromogenes 1pokOIV by conjugation. Exconjugants
were incubated on MS media supplemented with apramycin.
Bioinformatic Analysis of Foxicin
Biosynthetic Gene Cluster and
Identification of Similar Biosynthetic
Gene Cluster
The draft genome of S. diastatochromogenes Tü6028 was
sequenced at the Centrum of Biotechnology, University of
Bielefeld (Greule et al., unpublished). Prediction of the
gene clusters was performed using antiSMASH 3.01 (Weber
et al., 2015a). The sequence of foxicin 57.6 kb hybrid PKS
I/NRPS biosynthetic gene cluster was further analyzed and
annotated using BLAST2. Similar gene clusters were identified by
antiSMASH and BLAST analysis in other Streptomyces strains.
The genomes of these strains were analyzed individually by the
above mentioned programs.
Phylogenetic Tree of fox Homologous
Clusters
A phylogenetic tree was calculated by Clustal Omega (Sievers
et al., 2011) using Neighbor-Joining method of foxBII sequence
comparison. For better illustration, the tree is shown without
distance correction.
Siderophore Chrome Azurol S (CAS) –
Assay
Chrome azurol S medium was modified after Schwyn and
Neilands (1987). For the CAS medium 60.5 mg CAS, 72.9 mg
hexadecyltrimetyl ammonium bromide, and 30.24 g piperazine-
1,4-bis-(2-ethanesulfonic acid) were dissolved in 990 mL water
and mixed with 10 mL iron (III) solution (1 mM FeCl3 × 6H2O
and 10 mM HCl). Purified foxicin A was pipetted to CAS reagent
and a color change of the dark blue solution to violet was noted.
Shift of UV/vis Spectra in the Presence of
Iron
Foxicin A was dissolved in MeOH. FeCl3 and FeSO4 were added
in an amount of 0.5 mM to 100 mM. UV/vis spectra were
measured by UviLine 9400 spectrophotometer (SI Analytics).
Isolation of Bacterial Plasma Membranes
Escherichia coli BW25113 cells were grown aerobically (180 rpm)
at 37◦C in baﬄed flasks using LB-medium. The cells were
1http://antismash.secondarymetabolites.org/
2http://blast.ncbi.nlm.nih.gov
harvested by centrifugation (5700 × g, 10 min, 4◦C, Rotor
JLA 8.1000, Avanti J-26 XP, Beckman Coulter) in the late
exponential phase yielding approximately 6.5 g cells/L. All further
steps were carried out at 4◦C. After centrifugation, 5 g of the
cell pellet were resuspended in fourfold volume of buffer 1
(50 mM MES/NaOH, pH 6.0, 50 mM NaCl, 0.1 mM PMSF
supplemented with desoxyribonuclease I) and disrupted by
passing twice through a French Pressure Cell Press (110 MPa,
SLM-Aminco). Cell debris and non-disrupted cells were removed
by centrifugation (9500 × g, 20 min, 4◦C, Rotor A8.24, RC-5
Superspeed Refrigerated Centrifuge, Sorvall Instruments). The
cytoplasmic membranes were obtained from the supernatant by
centrifugation at 252000 × g (60 min, 4◦C, Rotor 70.1Ti, L8-M
Ultrafuge, Beckman). The sediment was suspended in an equal
volume (1:1, w/v) of buffer 1 and was used directly or frozen in
liquid nitrogen and stored at−80◦C.
Determination of NADH Oxidase Activity
The NADH oxidase activity of cytoplasmic membranes was
measured with a Clark-type oxygen electrode (RE K1-1, Oxytec)
at 30◦C. To calibrate the electrode 2 mL 50 mM MES/NaOH, pH
6.0, 50 mM NaCl, 5 mM MgCl2 were deoxygenized by adding
sodium dithionite and the signal was set to 237 µM oxygen
(Weiss, 1970). Each measurement was performed with 2 mL
buffer containing 5 µL of the membrane suspension at 30◦C.
The reaction was started by adding 1.25 mM NADH. 50–500 µM
foxicin A was added to the assay to test its inhibitory action on
cell respiration.
Agar Diffusion Assay
Antimicrobial activity of foxicin A was determined by the
agar plate diffusion method on a paper disk (6 mm diameter).
100 µg per disk of foxicin A were tested against Streptomyces
viridochromogenes Tü57 (Hütter, 1962), Actinokineospora
bangkokensis (Intra et al., 2013), Saccharothrix espanaensis
(Kong et al., 1998), Bacillus subtilis (Ehrenberg) COHN
ATCC6051 (American Type Culture Collection, 18th Edition,
1992), E. coli XL1-Blue, Fusarium verticillioides DSM 62264,
Candida parapsilosis DSM 5784, Synechococcus sp. PCC7002 and
Synechocystis sp. PCC6803, Mycobacterium smegmatis mc2 155.
The compound was dissolved in methanol. After evaporation of
the methanol, disks were fixed on the test-plates and incubated
over night at 30 or 37◦C. Polyketomycin, apramycin, and
methanol were used as controls. The following media were used
for the assay: LB-medium (tryptone 1%, yeast extract 0.5%,
NaCl 0.5%) for E. coli and Bacillus, MS medium (soya flour
2%, mannitol 2%) for actinomycetes strains, BG11-medium
(NaNO3 0,15%, K2HPO4 0.004%, MgSO4 × 7H2O 0.0075%,
CaCl2 × 2H2O 0.0036%, citric acid 0.0006%, ammonium ferric
citrate 0.0006%, EDTA 0.0001%, Na2CO3 0.002%, trace elements
1.0 mL) for cyanobacterial strains, PDA-medium (potato extract
0,4%, dextrose 2%) for Fusarium, YPD-medium (yeast extract
1%, peptone 2%, glucose 2%) for Candida and Middlebrook
7H9 Broth (7H9 broth base 0.52%, 40% glycerol 5.5 mL) for
Mycobacterium. For agar plates 2% agar-agar was added to the
media.
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To assay the herbicidal property, 0.1, 1, and 5 µM of foxicin
A was added to 6 mg of Arabidopsis thaliana wt ecotype
Wassilewskija seeds that were plated onto plates. The plants were
grown for 2 weeks in a phytochamber with long-day conditions
(16/8 h), 100 µE m−2 s−1 light intensity and 25◦C constant
temperature.
To check for H2O2 sensitivity, 2, 5, and 10 µL of 5% H2O2
solution were pipetted on paper disks (6 mm diameter) and
placed on MS and TSB culture plates of S. diastatochromogenes
WT, 1pokOIV mutant and 1pokOIV/foxBII::pKC1132 mutant.
The strains were incubated at 28◦C for 5 days and inhibition zone
was measured.
Cell Viability Assay (MTT-Assay)
The effect on cell viability of foxicin A was tested against
cancer cell lines CCRF-CEM, CEM-ADR5000 and Jurkat cells
and peripheral blood mononuclear cells (PBMC) using the MTT
assay as previously described (Calderón et al., 2014). In brief, cells
were seeded in 96-well plates at a density of 4 × 104 cells/well
and incubated for 24 h with various concentrations of foxicin A.
The chemotherapeutic agent doxorubicin was used as a positive
control, and DMSO (0.1%) was the solvent control. The data are
expressed as the mean± SD of three independent experiments.
RESULTS
Production and Isolation of Foxicin A
from S. diastatochromogenes Tü6028
Streptomyces diastatochromogenes Tü6028 is known to synthesize
polyketomycin, which is produced at high levels after 96 h of
cultivation in HA medium. During our studies on polyketomycin
biosynthesis we deleted the oxygenase gene pokOIV (Daum et al.,
2009). The mutant failed to produce polyketomycin, instead
we observed the accumulation of novel compounds, which we
named foxicin A, B, C, and D (minor compounds) (Figure 2A).
A careful analysis of extracts of the wild type strain showed that
foxicins are also produced, but with significantly lower titers.
Foxicin production in the wt strain reaches a maximum after 48 h
of incubation (Figure 2B). After 96 h less than 5% of the initial
foxicin A concentration was detected. In S. diastatochromogenes
1pokOIV, foxicin production reaches its maximum after 6 days.
The mutant also produces fewer spores and visibly lower amounts
of melanin, as indicated by the color of the cultivation medium
(Figure 2C). Cultivation of S. diastatochromogenes 1pokOIV in
5 L of HA production medium yielded 9.8 mg of foxicin A
(1.96 mg/L) and 3.4 mg of foxicin B (0.68 mg/L), and even lower
amounts of foxicins C and D.
Physiocochemical Properties and
Structure Elucidation of Foxicin A
The physicochemical properties of foxicin A are summarized
in Supplementary Table S1. Foxicin A is soluble in common
organic solvents such as MeOH, CH3CN, CHCl3 and DMSO,
but is insoluble in H2O. HR-ESI-MS analysis (m/z found:
346.1532; calculated: 346.1529) revealed the molecular formula
as C18H22N2O5. The UV/vis light spectra of the foxicin derivates
A–D are similar (Supplementary Figure S1). Foxicin A shows
absorption maxima at 246, 280, 316, 390 and a small peak at
462 nm.
NMR-data of foxicin A were recorded in CDCl3 and DMSO-
d6. In Supplementary Tables S2 and S3, NMR assignments of
1D NMR (1H, 13C) and 2D NMR (1H-1H-COSY, HSQC, H2BC,
and HMBC) experiments are summarized and Supplementary
Figures S2–S14 show the respective spectra. The 13C NMR
spectrum shows 18 carbon signals, which could be assigned to
five methyl, three methine groups and nine quarternary carbon
atoms by the use of HSQC. A 1,4-benzoquinone system was
identified from typical carbonyl chemical shifts (δC = 182.3
and δC = 178.6 ppm). The benzoquinone is substituted with a
hydroxyl group in position C-2 and an amino-acetate at position
C-3, as established by HMBC correlations C-2/6-H, C-2/1′-NH,
FIGURE 2 | Production of polyketomycin and foxicin in Streptomyces diastatochromogenes Tü6028. (A) HPLC chromatogram of S. diastatochromogenes
Tü6028 wild type at λ430 nm with polyketomycin structure (top) and of 1pokOIV mutant at λ320 nm (below); (B) Production of foxicin A (N) and polyketomycin (O)
in S. diastatochromogenes Tü6028 wild type; (C) Morphology of S. diastatochromogenes Tü6028 wild type (left) and 1pokOIV mutant (right). On the plate, the
1pokOIV mutant appears yellow and deficient in producing spores and melanins (dark color).
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FIGURE 3 | Important NMR correlations of foxicin A.
and C-4/1′-NH. Moreover, an additional side chain is attached
at C-5 via an amide functionality, as proven by the HMBC
signals C-4/1′′-NH and C-6/1′′-NH. The side chain contains two
double bonds, which are both trisubstituted. One double bond is
in conjugation to the amide carbonyl as proven by the HMBC
signal C-2′′/4′′-H and bears a methyl group at C-3′′ as shown
by the HMBC cross peaks C-2′′/3′′-CH3, 3′′-CH3/4′′-H, this
double bond is in E configuration as proven by the ROESY signal
3′′-CH3/5′′-H. The second double bond was determined as a C-
6′′ = C-7′′ double bond with two methyl groups at C-7′′ based
on HMBC correlations. The two double bonds are connected via
the C-5 methine group, which is methyl substituted as established
by COSY couplings 4′′-H/5′′-H, 5′′-H/6′′-H and H2BC signals
C′′-5/4′′-H and C-5′′/6′′-H. The important 2D correlations are
shown in Figure 3.
Based on our 1- and 2D NMR data, the absolute configuration
of foxicin A could not be solved unambiguously. Therefore,
we analyzed this compound by comparing vibrational circular
dichroism (VCD) and infrared (IR) spectra to spectra from
quantum chemical calculations. A molecular model of foxicin A
was constructed and subjected to a conformer search algorithm
employing molecular mechanics (MMFF). The conformer
models were then subjected to a geometry optimization at the
DFT level [B3LYP/6-31+G(d,p)] and the relative energies and IR
absorbance and VCD intensities were calculated. The comparison
of the Boltzmann-weighted average of the spectra calculated
for five conformers of foxicin A and the experimental VCD
spectrum (Figure 4) allowed for the assignment of the absolute
conformation as well as the configuration of foxicin A as (S)-
2-hydroxy-3-(acetylamino)-5-(3′′, 5′′S, 7′′-trimethyl-hepta-3′′E,
6′′-dienoylamino)-1,4-benzoquinone. The structure of foxicin A
is shown in Figure 1.
Foxicin B has the same mass (346 g/mol) as foxicin A. Foxicin
C and foxicin D are only produced in low amounts. Both
compounds have a molecular weight of M = 360 g/mol, based on
the deprotonated molecular ion peak at m/z 359.2 in the negative
ion mode CI-MS spectrum.
Identification and Sequence Analysis of
the Biosynthetic Gene Cluster
Due to its chemical structure, foxicin A is likely to be a product of
a type I polyketide synthase (PKSI) and a non-ribosomal peptide
synthetase (NRPS). Bioinformatics analysis of the 7.9 Mb draft
FIGURE 4 | Infrared and VCD spectra of foxicin A. (A) Experimental IR
spectra recorded for foxicin A (red) overlayed with IR spectra calculated at the
B3LYP/6-31+G(d,p) level for the ortho-quinone (black) and for the
para-quinone (blue) with considerably better agreement for para (spectra are
offset for better comparison); (B) Experimental (red) VCD and dissymmetry
factor spectra in comparison to VCD and dissymmetry factor spectra
calculated for (S)-foxicin (blue). The good overall agreement allows for
assignment of the S-configuration.
genome sequence of S. diastatochromogenes Tü6028 revealed
23 putative secondary metabolite gene clusters, but only one
cluster containing genes with both PKSI- and NRPS function.
The cluster was assigned to 57.6 kb with an overall GC content
of 72.4%. The annotation analysis revealed 41 open reading
frames (ORFs) putatively involved in foxicin A-D biosynthesis
(Table 1). The genetic organization of the biosynthetic gene
cluster (fox gene cluster) is shown in Figure 5A. The GenBank
accession number of the nucleotide sequence is KT440882. In
order to verify the correct assignment of the fox gene cluster,
we constructed the inactivation plasmid pKC1132_SC_foxBII
containing a 2 kb homologous region of foxBII. Conjugation
between E. coli ET12567 and S. diastatochromogenes Tü6028
1pokOIV and integration of the plasmid into foxBII by
single crossover recombination resulted in apramycin-resistant
mutants. Integration of the plasmid into foxBII by single
crossover recombination was confirmed by PCR. Loss of ability
of the mutant strain to produce foxicins confirmed the correct
assignment of the fox gene cluster.
Characterization of the Deduced Amino
Acid Sequences and Putative Model of
the Biosynthesis of Foxicins
Based on bioinformatics analysis of the fox gene cluster of
S. diastatochromogenes Tü6028, a putative biosynthetic pathway
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TABLE 1 | Proposed functions of open reading frames in the foxicin
biosynthetic gene cluster.
ORF aa Proposed function
foxTI 422 ABC transporter, substrate binding
foxTII 304 ABC transporter, permease
foxTIII 309 ABC transporter, permease
foxHI 66 Hypothetical protein
foxHII 65 Hypothetical protein
foxC 346 ATP/GTP binding protein
foxD 451 Dipeptidase / deacetylase
foxOI 409 Hydrogenase
foxHIII 153 Hypothetical protein
foxRI 237 TetR transcriptional regulator
foxRII 417 Two-component system sensor kinase
foxRIII 221 Two-component system response regulator
foxHIV 81 Hypothetical protein
foxTIV 493 Transmembrane efflux protein
foxRIV 137 MarR transcriptional regulator
foxHV 246 Hypothetical protein
foxTV 399 Integral membrane transport protein
foxA 371 Acetyl transferase
foxGI 481 Glyceraldehyde-3-phosphate dehydrogenase
foxBI 583 Non-ribosomal peptide synthetase (A-domain)
foxBII 4807 Modular polyketide synthase
(ACP-KS-AT-DH∗-KR-ACP-KS-AT-DH-KR-ACP),
non-ribosomal peptide synthetase (C-domain), FkbH
foxBIII 945 Non-ribosomal peptide synthetase (PCP-TE)
foxEI 378 Esterase
foxEII 259 Carboxylesterase
foxTVI 131 Drug resistance transporter
foxTVII 253 Drug resistance transporter
foxRV 261 Regulator
foxGII 306 Sugar isomerase
foxGIII 283 Sugar-bisphosphate aldolase
foxHVI 99 Hypothetical protein
foxOII 259 Dioxygenase
foxRVI 257 AraC family transcriptional regulator
foxRVII 380 rRNA methyltransferase
foxRVIII 241 Alkylated DNA repair protein
foxRIX 371 ROK family transcriptional regulator
foxEIII 310 Phosphotriesterase
foxHVII 194 Hypothetical protein
foxRX 191 TetR family transcriptional regulator
foxTVIII 101 Membrane protein
foxTIX 252 ABC transporter, ATP-binding protein
foxTX 853 ABC transporter, substrate-binding protein
for foxicins’ biosynthesis is proposed. The 14.4 kb gene foxBII
encodes a protein with predicted modular type I polyketide
synthase function, with one loading module, two extender
modules, a FkbH-like domain, and one condensation domain
(C) of a NRPS. The loading module of FoxBII contains only one
ACP. Based on the structure of foxicin A we propose isobutyryl-
CoA as being the respective starter unit. Module I and II consist
of a ketosynthase (KS), acyltransferase (AT), dehydratase (DH),
ketoreductase (KR) and an ACP domain, respectively. Both
ATs show specificity for methylmalonyl-CoA as predicted using
antiSMASH (Weber et al., 2015a), which is in line with the
structure of foxicin A.
Foxicin A possesses a double bond between the starter unit
and the first extender unit in β,γ-position. Similar structural
elements are known from ansamitocin-, rhizoxin-, bacillaen and
corallopyronin. It has been shown that special dehydratases or
additional shift modules are responsible for the double bond
shift in β,γ-position during the biosynthesis of these molecules
(Taft et al., 2009; Kusebauch et al., 2010; Moldenhauer et al.,
2010; Lohr et al., 2013). In some DH domains, the conserved
motif is mutated. The DH domain of module I of the fox cluster
shows in contrast to other DH domains a motif of HxxxGxxxxS
instead of the conserved HxxxGxxxxP motif, indicating that this
domain could introduce the β,γ-double bond during foxicins’
biosynthesis.
The FkbH-like domain is likely to incorporate a glyceryl
moiety (Chan et al., 2006; Dorrestein et al., 2006; Sun et al., 2008).
The three genes foxGI, foxGII and foxGIII, also located in the
fox biosynthetic gene cluster, encode for enzymes known to be
involved in sugar metabolism. The proposed functions of the
enzymes are glyceraldehyde-3-phosphate dehydrogenase, sugar
isomerase and aldolase. Most likely the three of them provide
bisphosphoglycerate, which is transferred onto the carrier protein
of FoxBIII.
The adenylation domain (A) might be encoded by foxBI,
which is separated from foxBIII by the PKS gene foxBII. In silico
analysis did not indicate an A domain specificity, but based on
the structure of foxicin A, a non-proteinogenic amino acid with
two amide groups similar to 2,4-diamino-3-oxobutanoic acid
might play a role. This moiety is then most likely linked to the
glyceryl-CP.
We propose that the biosynthesis starts with the PKS I of
FoxBII and the generated polyketide chain is then transferred
onto the amino acid bound to the glyceryl-CP of FoxBIII. Finally,
the molecule is cleaved from the enzyme by the thioesterase
domain (TE) of FoxBIII, followed by the ring formation. The
responsible enzyme for the ring formation is unknown, but
with BLAST analysis we identified candidate genes as foxEI or
foxEII, with proposed esterase activity. N-acetylation catalyzed
by FoxA results ultimately in foxicin A (Figure 6). After
cleavage from the enzyme complex foxicin A gets further
modified.
At each end of the fox gene cluster two ABC transporter genes
are located (foxTI-TIII and foxTVIII-X). In addition, foxTIV
encodes a transmembrane eﬄux protein, foxTV an integral
membrane transport protein, foxTVI a transporter belonging
to the EmrB/QacA family and foxTVII, an export protein. The
biosynthetic gene cluster of foxicins also includes 10 regulatory
proteins (FoxRI-FoxRX), indicating a complex regulation of the
outlined biosynthesis.
Similar fox Biosynthetic Gene Clusters in
Various Streptomyces Strains
Similar fox gene clusters were identified in the genomes of 21
additional Streptomyces strains (Figures 5C,D): S. aureus NRRL
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FIGURE 5 | Foxicin biosynthetic gene clusters in different Streptomyces strains. (A) Organization of the foxicin biosynthetic gene cluster in
S. diastatochromogenes Tü6028. The fox gene cluster spans 57.6 kb and contains 41 ORFs. Genes are indicated by different arrowheads according to their
proposed function. (B) Phylogenetic tree based on Neighbor Joining without distance corrections of sequence comparison of foxBII, (C) homologous fox gene
clusters in other Streptomyces strains, (D) predicted gene function and (E) domain assembly line of biosynthesis genes and (F) predicted domain function.
B-1941 (Doroghazi et al., 2014), S. avermitilis MA4680 (Ikeda
et al., 2003), S. bicolor NRRL B-5348 (Doroghazi et al., 2014),
S. bingchenggensis BCW-1 (Wang et al., 2010), S. bungoensis
DSM 41781, S. caeruleatus NRRL B-24802, S. cellostaticus
DSM 40189, S. collinus Tü365 (Rückert et al., 2013), S. curacoi
DSM 40107, S. incarnatus NRRL 8089 (Oshima et al., 2015),
S. mangrovisoli DSM 100438, S. olivochromogenes DSM
40451, S. puniciscabiei NRRL B-24456, S. regalis NRRL 3151,
S. viridochromogenes NRRL 3414, NRRL 3416 and NRRL_3413,
S. viridochromogenes Tü57 (Grüning et al., 2013), Streptomyces
sp. 142MFCol3.1, Streptomyces sp. JHA19 (Matsunaga et al.,
2015) and Streptomyces sp. OK006 (Klingeman et al., 2015).
In these strains homologs of foxBI, foxBII, foxBIII, foxEI,
and foxEII are located next to each other with high sequence
identities of 73% up to 96% (Supplementary Table S4). The
closest homologous cluster is located in Streptomyces sp.
142MFCol3.1. A phylogenetic tree based on foxBII sequence
analysis is shown in Figure 5B. In all strains the NRPS/PKS I
hydride enzyme complex (foxBI – foxBIII) consists of the same
series of catalytic domains ([A] – [ACP-KS-AT-DH-KR-ACP-
KS-AT-DH-KR-ACP-C-FkbH] – [PCP-TE]) (Figures 5E,F). The
strains Streptomyces sp. JHA19, S. curacoi and S. regalis have an
additional PKS/NRPS hybrid gene upstream of foxBI-III with
[A-PCP-KS-AT-KR-ACP-C-A-PCP-C] catalytic domains. The
phylogenetic tree that is based on foxBII illustrates that the
biosynthetic gene clusters of these strains do not originate from
one clade.
In most of the strains foxEI and foxEII reside adjacent to
foxBI-foxBIII indicating that they might play an important role in
the biosynthesis of these secondary metabolites. Additionally, in
most of the clusters genes from sugar and amino acid metabolism,
as well as methyl-/acetyl transferases were identified.
The described genes in the predicted fox clusters do not
agree in detail, therefore we assume that the corresponding
compounds might exhibit structural differences. Considering
the discrete array of catalytic domains, however, we expect
similar polyketide tails in all foxicins A–D-like substances. To
the best of our knowledge, none of the mentioned strains
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FIGURE 6 | Proposed biosynthetic pathway of foxicin. FoxBII is proposed to be involved in the formation of the polyketide side chain (blue), FoxBI and FoxBIII in
the incorporation of an amino acid (dark red) and FoxGI-III with FkbH domain of FoxBII in the incorporation of a C2 sugar moiety (green). N-acetylation might be
catalyzed by FoxA (magenta).
synthesizes a compound related to foxicins. The responsible
gene clusters seem to be silent or have, until now, not been
studied. In Supplementary Table S4, an overview of the described
Streptomyces strains is shown, as well as their known secondary
metabolites and the percentage identity of the identified genes
with foxBI, foxBII, foxBIII, foxEI, and foxEII.
Activity of Foxicin A
In order to understand the function of foxicin A we attempted
to characterize this molecule in greater detail. By means of
LC-MS analysis we could show that Foxicin A production in
S. diastatochromogenes is inhibited by ferric ions supplemented
to the growth medium. The supplementation of either 1 mM
FeCl3 or FeSO4 to the production medium led to a more than
75-fold decrease in foxicin A formation in S. diastatochromogenes
1pokOIV (Figure 7A). The addition of FeCl3 to foxicin A
resulted in a shift of the UV/vis maximum at 320–350 nm
(Figure 7B). Using the CAS assay (Schwyn and Neilands, 1987),
we observed a color change from blue to violet (Figure 7C),
indicating that foxicin A acts as a siderophore.
As foxicin A contains a quinone moiety similar to molecules
involved in various redox processes within the cell (Brunmark
and Cadenas, 1989), the compound was tested for its property
as an electron acceptor or inhibitor of the respiratory chains.
Foxicin A was added to E. coli cytoplasmic membranes and
the respiratory chain activity was measured with a Clark-type
electrode by starting the reaction with NADH as electron
donor. 500 µM foxicin A blocked O2 consumption to 30%
indicating its role as a weak inhibitor of the electron transfer
chain (Supplementary Table S5). In contrast to other quinones
(Kawamukai, 2002) foxicin A does not protect cells from
oxidative stress induced by H2O2 (Supplementary Figure S15).
To identify the antibiotic potential of foxicin A, an inhibition
zone test was conducted. Therefore, 100 µg foxicin A were
applied to paper disks that were transferred to different
culture plates. The compound showed moderate activity against
Streptomyces viridochromogenes, Saccharothrix espanaensis and
the cyanobacterial strains Synechococcus sp. and Synechocystis
sp. The tested amount of foxicin A did not visibly influence
the growth of the bacterial strains E. coli XL1-Blue, Bacillus
subtilis, Mycobacterium smegmatis, the fungal strains Candida
parapsilosis and Fusarium verticillioides (Supplementary Table
S6) and the plant Arabidopsis thaliana. To determine the effect
of foxicin A on cell viability of human cells, leukemia cell lines
CCRF-CEM, CEM-ADR5000 and Jurkat cells as well as non-
cancer PBMCs were stimulated for 24 h with foxicin A at a
concentration range of 0.6–80 µM. However, foxicin A showed
no significant effect on cell viability, as measured by using the
MTT assay (Supplementary Figure S16).
DISCUSSION
As a result of the deletion of the structural gene pokOIV
of polyketomycin biosynthesis, we identified novel secondary
metabolites in S. diastatochromogenes Tü6028, named foxicins.
In the wild type strain, the gene cluster is expressed only
at low levels. In contrast, the 1pokOIV mutant produces
higher amounts of the foxicin derivatives A–D, enabling further
investigations of these fascinating compounds. Noteworthy, the
mutant strain produces less spores and melanin, indicating a
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FIGURE 7 | Interaction of foxicin with ferric ions. (A) Foxicin production with supplementation of different amounts of ferric ion, calculated integral of the foxicin
A peak at 320 nm/25 mL culture; (B) Shift of UV/vis spectrum of foxicin A in presence of FeCl3; (C) CAS-assay of foxicin A, color exchange from blue (left) to violet
(right).
crucial role of polyketomycin for the differentiation and stress
response.
The structure of foxicin A could not be completely elucidated
by NMR analysis. Eventually, the combination of NMR, IR,
and VCD spectra analysis led to the solution of the structure
of foxicin A. Foxicin A shows several unusual features. It has
a para-quinone moiety, with two amide groups on each site,
one is further acetylated and a short fatty acid side chain with
non-conjugated double bonds.
The structure of the compound and the encoding genes
in the fox cluster suggest a novel biosynthetic pathway. We
conclude that foxicins are hybrid compounds with structural
elements most probably derived from an amino acid, a C2-moiety
derived from sugar metabolism, a polyketide chain of isobutyryl-
CoA and methylmalonyl-CoA, and N-acetylation. Although
aminoquinones are common structural elements in natural
products, none of those that are known is similar to foxicin.
Compounds such as N-(3-carboxylpropyl)-5-amino-2-hydroxy-
3-tridecyl-1,4-benzoquinone from plant roots of Embelia ribes
(Lin et al., 2006), nakijiquinones A-I from marine sponges
(Shigemori et al., 1994; Kobayashi et al., 1995; Takahashi
et al., 2008, 2009), actinomycin of different Streptomyces strains
(Waksman and Gregory, 1954) and the large group of ansamycins
(Brufani et al., 1973; Oppolzer and Prelog, 1973; White et al.,
1973; Rinehart and Shield, 1976) and mitomycin/porfiromycin
(Webb et al., 1962), comprise a 3-amino-1,4-benzoquinone
moiety. In few cases, aminoquinones are substituted with an
additional amino group such as the Streptomyces products
abenquines A–D (Schulz et al., 2011), the antitumor compounds
streptonigrin (Rao and Cullen, 1959–1960) and lavendamycin
(Doyle et al., 1981), or the fungal pigments lepiotaquinone
(Spiteller et al., 2003) or lilacinone (Aulinger et al., 2000) and
aminoglycoside antibiotics such as streptomycin. For many of
these products, it was shown that the aminoquinone moiety
was built by either amination of glucose-6-phosphate (Llewellyn
and Spencer, 2006) or the aminoshikimate pathway (Floss et al.,
2011).
Quinone moieties are commonly found in natural products.
One major group are the ubiquinones, for example, being
important electron carriers in respiration and photosynthesis.
Furthermore, they are involved in all kinds of redox reactions
and play a crucial role as antioxidants (Kawamukai, 2002).
Their long isoprenoid chains lead to the ability to penetrate
biological membranes. The short polyketide tail of foxicin A
indicates that the compound is not located in the membrane.
Idebenone, a synthetic quinone with similarities to ubiquinones,
but with a much shorter, less lipophilic tail is predominantly
active in the cytoplasm and not in cellular membranes. It is
a potent antioxidant, prevents lipid peroxidation and protects
against ROS-induced damage in multiple systems (Suno and
Nagaoka, 1984; Sugiyama et al., 1985; Rauchová et al., 2006).
Foxicin A has even a shorter chain than idebenone. The presence
of foxicin A in the culture medium supports the assumption
that foxicin A activity is not associated with membrane
binding.
Like other quinones, foxicin A is able to accept electrons,
but does not act as an antioxidant. In vitro, foxicin A inhibits
respiratory function in E. coli membranes, without affecting the
in vivo viability of the strain. Foxicin A obstructs the growth
of other actinomycetes strains, as well as cyanobacterial species.
In contrast, the molecule does not visibly influence the growth
of Arabidopsis thaliana. Therefore, it may also interact with the
photosynthesis machinery, but cannot pass through all types of
cell walls. Further studies are needed to support this hypothesis.
The main function of the foxicins is most likely explained by
their ability to act as a siderophore. Surprisingly, foxicin A does
not inhibit the viability of human cells, even though it is able to
bind ions from the medium. Ions are essential for all organisms.
The lack of ions, especially ferric ions, often limits the growth
of bacteria in their natural habitat. Therefore, siderophores are
vital molecules that are released into the medium, and, after
scavenging ions, are actively transported back into the cell. The
strain S. diastatochromogenes 1pokOIV produces less foxicins in
the presence of ferric ions in the production media. Foxicin A
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interacts directly with iron as shown by the CAS assay and a shift
of the absorbance maximum in the UV/vis spectrum.
Investigations on siderophores are nowadays in the focus
of many research groups, in order to obtain new antibacterial
compounds, by employing the ‘trojan horse’ strategy. The outer
membrane is an important barrier of Gram-negative bacteria,
as well as of mycobacteria. Diarra et al. (1996) and Möllmann
et al. (2009) have intriguingly shown that the linkage of an
antibiotic to a siderophore can lead to facilitated transport via
specific transporters into the cell with subsequent death of the
pathogens.
The siderophore yersiniabactin has been found in the plague
bacterium Yersinia (Pelludat et al., 1998) and in other bacteria
such as the nematode symbiont Photorhabdus luminescens
(Duchaud et al., 2003), the plant pathogen Pseudomonas syringae,
pathogenic strains of E. coli (Bultreys et al., 2006) and even in
the Gram-positive marine bacterium Salinispora tropica (Udwary
et al., 2007). The ability to synthesize siderophores gives special
benefits to a strain and the evolutionary driving force to keep
the biosynthetic gene clusters. The foxicin cluster was identified
in more than twenty additional Streptomyces strains, which were
isolated at different places around the world, indicating an
evolutionary early origin. Until now (11/2016) genome sequences
of 844 Streptomyces strains are available on NCBI. This means
that the cluster is present in about 2.6% of all Streptomyces
strains. It is anticipated that further genome sequencing of many
more Streptomyces strains will reveal additional homologous fox
biosynthetic gene clusters. Surprisingly, the fox cluster was not
detected in any other actinomycetes genus. Although horizontal
gene transfer is common in the Streptomyces genus, it is
unexpected that the cluster is found in that many other strains.
In addition, the organization of the structural genes foxBI, foxBII,
foxBIII, foxEI, and foxEII remained the same with high sequence
similarity. Therefore, we assume that the respective products
should only by slightly different to foxicin A-D. In the three
strains comprising of additional PKS/NRPS genes, the product
might be more complex, e.g., possessing a second polyketide
chain. Many of the investigated strains are known producers of
secondary metabolites, but not of compounds similar to foxicins.
Therefore, the identified clusters seem to be silent in these
strains or the compound is produced only in very little amounts.
As a consequence, its presence could have been overlooked in
routine natural compound screening, as it had been the case for
polyketomycin. The high similarity of the clusters indicates an
evolutionary driving force to keep the biosynthetic gene clusters
in place and consequently a major role of the compounds for
Streptomyces strains.
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